Skip to main content
Jeffrey Travers, MD, Dermatology, Dayton, OH

Jeffrey B Travers MD


Professor, Dermatology, Indiana University School of Medicine

Join to View Full Profile
  • 725 Colonel Glenn HwyDayton, OH 45435

  • Phone+1 937-245-7200

  • Fax+1 937-245-7922

Dr. Travers is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Colorado
    University of ColoradoResidency, Dermatology, 1992 - 1995
  • OhioHealth/Riverside Methodist Hospital
    OhioHealth/Riverside Methodist HospitalInternship, Transitional Year, 1991 - 1992
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 1991

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2014 - 2025
  • IN State Medical License
    IN State Medical License 1995 - 2015
  • CO State Medical License
    CO State Medical License 1993 - 1995
  • Dermatology
    American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2007
  • Fellow (FAAD) American Academy of Dermatology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Early Assessment of Burn Severity in Human Tissue Ex Vivo with Multi-Wavelength Spatial Frequency Domain Imaging  
    Richard Simman, Nathan M Weir, Smita Krishnamurthy, Jeffrey B Travers, Michael Kent, ScienceDirect

Press Mentions

  • Laser Treatment for Non-Melanoma Skin Cancer
    Laser Treatment for Non-Melanoma Skin CancerSeptember 6th, 2024
  • Laser Treatment of Nonmelanoma Skin Cancer Gaining Ground
    Laser Treatment of Nonmelanoma Skin Cancer Gaining GroundAugust 21st, 2024
  • Trial Yields Evidence That Laser Resurfacing May Prevent NMSC in Aged Skin
    Trial Yields Evidence That Laser Resurfacing May Prevent NMSC in Aged SkinJune 11th, 2021
  • Join now to see all

Grant Support

  • Oxidized Lipids and UV ImmunosuppressionDAYTON VA MEDICAL CENTER2010–2028
  • Wounding Therapy and PhotocarcinogenesisWRIGHT STATE UNIVERSITY2014–2027
  • Oxidized lipids and microvesicle particles as effectors for chemical threats to skinWRIGHT STATE UNIVERSITY2023–2026
  • UVB radiation-generated microvesicle particles as effectors for photosensitivityWRIGHT STATE UNIVERSITY2021–2026
  • UVB radiation-generated microvesicle particles as effectors for photosensitivityWRIGHT STATE UNIVERSITY2021–2026
  • Platelet Activating Factor And Epidermal CytotoxicityNational Heart, Lung, And Blood Institute1999–2012
  • Bacterial Products As Potentiaters Of Atopic Dermatitis (AD)National Institute Of Allergy And Infectious Diseases2007–2010
  • Platelet Activating Factor And Epidermic CytotoxicityNational Heart, Lung, And Blood Institute2003–2007
  • Bacterial Products As Potentiaters Of ADNational Institute Of Allergy And Infectious Diseases2006
  • Platelet Activating Factor In Keratinocyte FunctionNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1997–2001

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: